NCT05886452

Brief Summary

The objective is to determine the percentages of past toric CL wearers (who dropped out of contact lens wear due to dissatisfaction with comfort or vision) who are satisfied with the comfort and vision of DT1fA contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 2, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

March 25, 2025

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

May 23, 2023

Results QC Date

March 4, 2025

Last Update Submit

March 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of Patients With Positive Ratings (>50 Out of 100) for Satisfaction of Comfort and Vision.

    A questionnaire will be administered. Subjects are asked to rate their satisfaction with comfort and vision on a scale of 0 to 100, with higher ratings indicating higher satisfaction with comfort and vision.

    After 30 days of DT1fA contact lens wear

Other Outcomes (2)

  • Percentage of Patients Reporting Satisfaction of Overall and End of Day (EOD) Comfort and Vision; Comfort and Vision Under Real-world Conditions Related to Computer (or Tablet) Usage and Cellphone Usage.

    After 30 days of DT1fA contact lens wear

  • Percentage of Patients Reporting a Desire to Remain in DT1fA Lenses After Study is Concluded.

    After 30 days of DT1fA contact lens wear

Study Arms (1)

DT1fA contact lenses

Subjects fitted with DT1fA contact lenses

Device: DT1fA contact lenses

Interventions

Subjects will be fitted with DT1fA contact lenses

DT1fA contact lenses

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Eligible test subjects will be 18 to 39 years of age with history of previous unsuccessful astigmatism contact lens wear.

You may qualify if:

  • Subjects are eligible for the study if they meet the following criteria:
  • Note: Ocular criteria must be met in both eyes.
  • Gender: Males and Females.
  • Subjects will be 18-39 years old.
  • History of previous unsuccessful astigmatism contact lens wearer with qualifying answer to screening questions:
  • I used to wear astigmatism correcting (toric) soft contact lenses.
  • \- (YES)
  • I stopped wearing my previous astigmatism correcting soft contact lenses because of one or more of the below reasons:
  • Poor or fluctuating vision
  • Discomfort
  • Other
  • Subjects must have 20/25 or better distance visual acuity in each eye with current best correction.
  • Good general health (defined by prescription medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
  • Ability to give informed consent.
  • Willing and able to spend time for the study (Subjects will be required to attend three study visits and wear contact lenses on days between study visits).

You may not qualify if:

  • Previous ocular surgery.
  • Inability to be fit with the DT1fA lens design.
  • Subjects that should be wearing a toric contact lens for best acuity but have chosen to continue in spherical contact lens wear.
  • History of Accutane use.
  • Ocular surface disease that in the investigator's opinion would interfere with contact lens wear.
  • History of comorbidities, including autoimmune disorders and diabetes.
  • Irregular astigmatism as identified by Pentacam.
  • History of Amblyopia.
  • History of Strabismus and/or history of eye muscle surgery.
  • History of Monovision.
  • Potential subjects who are pregnant.
  • The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
  • Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mann Eye Institute

Houston, Texas, 76134-2099, United States

Location

MeSH Terms

Conditions

Astigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr Phillip Brunson
Organization
Mann Eye Institute

Study Officials

  • Phillip Brunson, OD

    Mann Eye Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2023

First Posted

June 2, 2023

Study Start

August 1, 2023

Primary Completion

April 1, 2024

Study Completion

April 1, 2024

Last Updated

March 25, 2025

Results First Posted

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations